Yüklüyor......
Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?
Many recent studies have demonstrated the range of disorders in which monoclonal antibodies have a clinical role. The monoclonal antibody NA1/34, directed against a surface antigen present on lesional cells ('LCH cells'), has been found to localise in vivo to sites of disease. This review...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2149709/ https://ncbi.nlm.nih.gov/pubmed/8075008 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|